...
机译:成人难治性变性间变性淋巴瘤激酶-阳性间变性大细胞淋巴瘤的成功异体干细胞移植
Division of Hemato- oncology Department of Internal Medicine Chi-Mei Medical Center Tainan Taiwan;
Division of Hemato- oncology Department of Internal Medicine Chi-Mei Medical Center Tainan Taiwan;
Department of Pathology Chi- Mei Medical Center Yung- Kang City TainanTaiwan;
Division of Hemato- oncology Department of Internal Medicine National Cheng- Kung University Hospital Tainan Taiwan;
Division of Hemato- oncology Department of Internal Medicine Chi-Mei Medical Center Tainan Taiwan;
Division of Hemato- oncology Department of Internal Medicine Chi-Mei Medical Center Tainan Taiwan;
Anaplastic large cell lymphoma; Ki-1 lymphoma; ALK; Allogeneic stem cell transplantation;
机译:异种造血干细胞移植患者复发/难治性全身性血压大细胞淋巴瘤。 欧洲血液移植淋巴瘤工作组的回顾性分析
机译:克唑替尼用于复发或难治性间变性淋巴瘤激酶阳性的间变性大细胞淋巴瘤的I / II期研究和克唑替尼用于复发或难治性神经母细胞瘤的I期研究:多中心单臂开放标签试验的研究方案
机译:具有减少强度条件方案的成功结果,然后进行了同种异体造血干细胞移植,用于复发或难治性的促进性大细胞淋巴瘤
机译:致癌蛋白NPM-ALK诱导ubiquitination曲线变化的功能表征Ala1(+)促进大细胞淋巴瘤细胞
机译:了解JunB转录因子在间变性淋巴瘤激酶阳性,间变性大细胞淋巴瘤中的功能。
机译:Alectinib一种间变性淋巴瘤激酶(ALK)抑制剂可作为同种异体干细胞移植的桥梁适用于对化疗和brentuximab vedotin难治的ALK阳性间变性大细胞淋巴瘤患者
机译:相对型淋巴瘤激酶(ALK) - 阳性促进性大细胞淋巴瘤复发/化疗的肝硬化大细胞淋巴瘤(Crencibib)两相研究